{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:27:03Z","timestamp":1787902023381,"version":"build-2784847793"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003286","name":"Kuwait Foundation for the Advancement of Sciences","doi-asserted-by":"publisher","award":["P116-13MC-01"],"award-info":[{"award-number":["P116-13MC-01"]}],"id":[{"id":"10.13039\/501100003286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cancer-related pain is a complicated symptom that often coincides with fatigue, depression, and anxiety. Although many safe treatments are available, inadequate control of Cancer-related pain continues to lead to suffering in cancer patients. This study\u2019s aim is to describe pain control, and the pattern of change in opioid and adjuvant medication prescriptions, before and after referral to the Palliative Care Center.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a prospective cohort study in adult cancer patients the Palliative Care Center between January 1, 2016 and December 30, 2017. We measured pain intensity and other associated symptoms via the Revised Edmonton Symptom Assessment System (ESAS-r) and documented detailed analgesics and adjuvant medication history before starting any palliative care and on days 0, 3, 6, and 14.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis included 240 patients whose cancer-related pain, anxiety, and depression scores meaningfully improved by day 6. The changes in the median (interquartile ranges) of Cancer-related pain, anxiety, and depression scores from day 0 to day 6 were: 6 (4\u20138) to 3 (1\u20134); 6 (4\u20139) to 2 (1\u20134); and 3 (2\u20136) to 2 (1\u20134), respectively, with<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for all. Morphine was the most common opioid administered; the percentage using it increased from 20.4% (<jats:italic>n<\/jats:italic>\u2009=\u200949) before referral to 49.6% (<jats:italic>n<\/jats:italic>\u2009=\u2009119) on day 6 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The median morphine equivalent daily dose decreased from a median (interquartile ranges) of 60(31\u201393) mg\/day before referral to 34(22\u201366) mg\/day on day 6 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). There was also a statistically significant increase in the percentage of patients taking adjuvant medications, from 38.8% before referral to 84.2% on day 6 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Comparing D0 to D6, the number of patients using Gabapentinoids significantly increased from 57(23.75%) to 79(32.9%) (p\u2009&lt;\u20090.001), amitriptyline dramatically increased from 14 (5.8%) to 44 (18.3%) (p\u2009&lt;\u20090.001), and other antidepressant drugs increased from 15 (6.2%) to 34 (14.1%) (p\u2009&lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>After referral to the Palliative Care Center, patients\u2019 pain and other symptoms scores decreased significantly, even with lower median morphine equivalent daily doses, arguably through more appropriately directed opioid use. This is evidence for the effectiveness of the comprehensive program at the Palliative Care Center in Kuwait.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12904-021-00717-2","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T20:02:46Z","timestamp":1612382566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The pattern of change in opioid and adjuvant prescriptions for cancer pain before and after referral to a comprehensive program in the Palliative Care Center in Kuwait"],"prefix":"10.1186","volume":"20","author":[{"given":"Ameena Mohammed","family":"Al-Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7790-6917","authenticated-orcid":false,"given":"Wafaa Mostafa","family":"Abd-El-Gawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhi Mostafa","family":"AboSerea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman El Sayed","family":"ElShereafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Abdel Shakor","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Abd Elaziz","family":"ElSayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"717_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437\u201349.","journal-title":"Ann Oncol"},{"issue":"6","key":"717_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"V den Beuken-van Everdingen","year":"2016","unstructured":"den Beuken-van Everdingen V, Marieke HJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag. 2016;51(6):1070\u20131090.e1079.","journal-title":"J Pain Symptom Manag"},{"key":"717_CR3","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.2147\/JPR.S139715","volume":"10","author":"P Reis-Pina","year":"2017","unstructured":"Reis-Pina P, Lawlor PG, Barbosa A. Adequacy of cancer-related pain management and predictors of undertreatment at referral to a pain clinic. J Pain Res. 2017;10:2097\u2013107.","journal-title":"J Pain Res"},{"issue":"6","key":"717_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557\u201365.","journal-title":"J Clin Oncol"},{"key":"717_CR5","unstructured":"The WHO (2018) WHO\u2019s cancer pain ladder for adults. Http:\/\/ www.who.int\/cancer\/palliative\/painladder\/en\/. Accessed 3 Nov 2018."},{"key":"717_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0885-3924(96)00109-1","volume":"12","author":"J Stjernsw\u00e4rd","year":"1996","unstructured":"Stjernsw\u00e4rd J, Colleau SM, Ventafridda V. The World Health Organization cancer pain and palliative care program. Past, present, and future. J Pain Symptom Manag. 1996;12:65\u201372.","journal-title":"J Pain Symptom Manag"},{"key":"717_CR7","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:e58\u201368.","journal-title":"Lancet Oncol"},{"issue":"Suppl 7","key":"717_CR8","doi-asserted-by":"publisher","first-page":"vii139","DOI":"10.1093\/annonc\/mds233","volume":"23","author":"CI Ripamonti","year":"2012","unstructured":"Ripamonti CI, Santini D, Maranzano E, et al. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol. 2012;23(Suppl 7):vii139\u201354.","journal-title":"Ann Oncol"},{"key":"717_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1200\/JOP.2016.014837","volume":"12","author":"JA Paice","year":"2016","unstructured":"Paice JA, Lacchetti C, Bruera E. Management of chronic pain in survivors of adult cancers: ASCO clinical practice guideline summary. J Oncol Pract. 2016;12:757\u201362.","journal-title":"J Oncol Pract"},{"issue":"suppl 3","key":"717_CR10","doi-asserted-by":"crossref","first-page":"ES39","DOI":"10.36076\/ppj.2012\/15\/ES39","volume":"15","author":"D Koyyalagunta","year":"2012","unstructured":"Koyyalagunta D, Bruera E, Solanki DR, et al. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Phys. 2012;15(suppl 3):ES39\u201358.","journal-title":"Pain Phys"},{"issue":"6","key":"717_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jpainsymman.2008.06.006","volume":"37","author":"GD Hakonsen","year":"2009","unstructured":"Hakonsen GD, Strelec P, Campbell D, Hudson S, Loennechen T. Adherence to medication guideline criteria in cancer pain management. J Pain Symptom Manag. 2009;37(6):1006\u201318.","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"717_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0885-3924(03)00220-3","volume":"26","author":"P Shvartzman","year":"2003","unstructured":"Shvartzman P, Friger M, Shani A, Barak F, Yoram C, Singer Y. Pain control in ambulatory cancer patients: can we do better? J Pain Symptom Manag. 2003;26(2):716\u201322.","journal-title":"J Pain Symptom Manag"},{"issue":"12","key":"717_CR13","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","volume":"19","author":"S Deandrea","year":"2008","unstructured":"Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985\u201391.","journal-title":"Ann Oncol"},{"issue":"36","key":"717_CR14","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","volume":"32","author":"M Greco","year":"2014","unstructured":"Greco M, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32(36):4149\u201354.","journal-title":"J Clin Oncol"},{"issue":"4","key":"717_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00520-012-1646-x","volume":"21","author":"JH Kwon","year":"2013","unstructured":"Kwon JH, Oh SY, Chisholm G, et al. Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report. Support Care Cancer. 2013;21(4):1175\u201383.","journal-title":"Support Care Cancer"},{"key":"717_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/PSY.0b013e3182590904","volume":"74","author":"HL Wang","year":"2012","unstructured":"Wang HL, Kroenke K, Wu J, et al. Predictors of cancer-related pain improvement over time. Psychosom Med. 2012;74:642\u20137.","journal-title":"Psychosom Med"},{"key":"717_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11916-003-0045-x","volume":"7","author":"PD Thielking","year":"2003","unstructured":"Thielking PD. Cancer pain and anxiety. Curr Sci Inc. 2003;7:249\u201361. https:\/\/doi.org\/10.1007\/s11916-003-0045-x.","journal-title":"Curr Sci Inc"},{"key":"717_CR18","doi-asserted-by":"publisher","first-page":"39397","DOI":"10.1038\/srep39397","volume":"7","author":"X Li","year":"2017","unstructured":"Li X, Xiao W, Yang P, et al. Psychological distress and cancer pain: results from a controlled cross-sectional survey in China. Sci Rep. 2017;7:39397. https:\/\/doi.org\/10.1038\/srep39397.","journal-title":"Sci Rep"},{"issue":"1","key":"717_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10147-009-0009-1","volume":"15","author":"H Takahashi","year":"2010","unstructured":"Takahashi H, Shimoyama N. A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. Int J Clin Oncol. 2010;15(1):46\u201351.","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"717_CR20","first-page":"E547","volume":"16","author":"M Nishihara","year":"2013","unstructured":"Nishihara M, Arai YC, Yamamoto Y, et al. Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Phys. 2013;16(5):E547\u201352.","journal-title":"Pain Phys"},{"issue":"6","key":"717_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/1049909108322288","volume":"25","author":"S Mishra","year":"2009","unstructured":"Mishra S, Bhatnagar S, Gupta D, Nirwani Goyal G, Jain R, Chauhan H. Management of neuropathic cancer pain following WHO analgesic ladder: a prospective study. Am J Hosp Palliat Care. 2009;25(6):447\u201351.","journal-title":"Am J Hosp Palliat Care"},{"issue":"4","key":"717_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/aas.12068","volume":"57","author":"GP Kurita","year":"2013","unstructured":"Kurita GP, Tange UB, Farholt H, et al. Pain characteristics and management of inpatients admitted to a comprehensive cancer Centre: a cross-sectional study. Acta Anaesthesiol Scand. 2013;57(4):518\u201325.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"717_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00520-014-2415-9","volume":"23","author":"S Shinde","year":"2015","unstructured":"Shinde S, Gordon P, Sharma P, Gross J, Davis MP. Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements? Support Care Cancer. 2015;23(3):695\u2013703.","journal-title":"Support Care Cancer"},{"issue":"3","key":"717_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/papr.12459","volume":"17","author":"MH van den Beuken-van Everdingen","year":"2017","unstructured":"van den Beuken-van Everdingen MH, de Graeff A, Jongen JL, Dijkstra D, Mostovaya I. Vissers KC; national guideline working group \u201cdiagnosis treatment of cancer pain\u201d. Pharmacological treatment of pain in Cancer patients: the role of adjuvant analgesics, a systematic review. Pain Pract. 2017;17(3):409\u201319.","journal-title":"Pain Pract"},{"issue":"4","key":"717_CR25","first-page":"180","volume":"32","author":"M Swami","year":"2018","unstructured":"Swami M, Case AA. Effective palliative care: what is involved? Oncology. 2018;32(4):180\u20134.","journal-title":"Oncology"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","volume":"32","author":"MT Greco","year":"2014","unstructured":"Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32:4149\u201354.","journal-title":"J Clin Oncol"},{"key":"717_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0304-3959(00)00482-6","volume":"92","author":"M Bennett","year":"2001","unstructured":"Bennett M. The LANSS pain scale: the Leeds assessment of neuropathic symptoms and sign. Pain. 2001;92:147\u201357.","journal-title":"Pain"},{"issue":"12","key":"717_CR28","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1007\/s00520-013-1921-5","volume":"21","author":"J Hardy","year":"2013","unstructured":"Hardy J, Quinn S, Fazekas B, Agar M, Currow D. Can the LANSS scale be used to classify pain in chronic cancer pain trials? Support Care Cancer. 2013;21(12):3387\u201391. https:\/\/doi.org\/10.1007\/s00520-013-1921-5.","journal-title":"Support Care Cancer"},{"key":"717_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6\u20139.","journal-title":"J Palliat Care"},{"key":"717_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00520-008-0522-1","volume":"17","author":"S Watanabe","year":"2009","unstructured":"Watanabe S, Nekolaichuk C, Beaumont C, Mawani A. The Edmonton symptom assessment system: what do patients think? Support Care Cancer. 2009;17:675\u201383.","journal-title":"Support Care Cancer"},{"key":"717_CR31","doi-asserted-by":"publisher","unstructured":"Shamieh O, Amin Z, Farsakh FA, et al. (2018) Validation of Edmonton symptom assessment system (ESAS) in Arabic language (ESAS-A). MASCC\/ISOO annual meeting on supportive care in cancer. https:\/\/doi.org\/10.26226\/morressier.5afadd8bf314ac000849af89","DOI":"10.26226\/morressier.5afadd8bf314ac000849af89"},{"key":"717_CR32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","volume":"53","author":"D Hui","year":"2017","unstructured":"Hui D, Bruera E. The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manag. 2017;53:630\u201343.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"717_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00520-013-2034-x","volume":"22","author":"CI Ripamonti","year":"2014","unstructured":"Ripamonti CI, Bandieri E, Pessi MA, Maruelli A, Buonaccorso L, Miccinesi G. The Edmonton symptom assessment system (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up. Support Care Cancer. 2014;22(3):783\u201393. https:\/\/doi.org\/10.1007\/s00520-013-2034-x.","journal-title":"Support Care Cancer"},{"key":"717_CR34","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.","edition":"5"},{"issue":"2","key":"717_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0304-3959(89)90131-0","volume":"37","author":"E Bruera","year":"1989","unstructured":"Bruera E, MacMillan K, Hanson J, et al. The Edmonton staging system for cancer pain: a preliminary report. Pain. 1989;37(2):203\u20139 Published Online First: 1989\/05\/01]17.","journal-title":"Pain"},{"issue":"3","key":"717_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jpainsymman.2004.05.008","volume":"29","author":"RL Fainsinger","year":"2005","unstructured":"Fainsinger RL, Nekolaichuk CL, Lawlor PG, et al. A multicenter study of the revised Edmonton staging system for classifying cancer pain. J Pain Symptom Manag. 2005;29(3):224\u201337.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"717_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/082585971403000406","volume":"30","author":"RL Fainsinger","year":"2014","unstructured":"Fainsinger RL, Nekolaichuk C, Muller V. Assessing and classifying cancer pain: can we develop an internationally accepted common language? J Palliat Care. 2014;30(4):279\u201383 Published Online First: 2014\/01\/01.","journal-title":"J Palliat Care"},{"key":"717_CR38","doi-asserted-by":"crossref","unstructured":"M. Fallon, R. Giusti, F. Aielli, P. Hoskin, R. Rolke, M. Sharma & C. I. Ripamonti, on behalf of the ESMO Guidelines Committee* Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines\u2020. Ann Oncol. 2018; 29 (Supp 4): iv166\u2013iv191.","DOI":"10.1093\/annonc\/mdy152"},{"key":"717_CR39","volume-title":"The sixth edition Palliative Care Formulary (PCF6)","author":"R Twycross","year":"2018","unstructured":"Twycross R, Wilcock A, Howard P. The sixth edition Palliative Care Formulary (PCF6). ISBN: 978\u20130\u20138571134-8-1. London: Pharmaceutical Press; 2018."},{"key":"717_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJM199403033300902","volume":"330","author":"C Cleeland","year":"1994","unstructured":"Cleeland C, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"717_CR41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jpainsymman.2006.05.024","volume":"32","author":"PB Russell","year":"2006","unstructured":"Russell PB, Aveyard SC, Oxenham DR. An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symptom Manag. 2006;32(6):581\u20138.","journal-title":"J Pain Symptom Manag"},{"key":"717_CR42","first-page":"CD012592","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7:CD012592.","journal-title":"Cochrane Database Syst Rev"},{"key":"717_CR43","doi-asserted-by":"crossref","unstructured":"Zeppetella G, Davies AN. Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev. 2013;10.","DOI":"10.1002\/14651858.CD004311.pub3"},{"key":"717_CR44","unstructured":"Cancer Action Team Holistic Common assessment of supportive and palliative care needs for adults with cancer: assessment guidance. London. Cancer Action Team. 2007. Holistic patient assessment --PEPSI COLA aide memoire."},{"key":"717_CR45","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1002\/cncr.26082","volume":"117","author":"R Dev","year":"2011","unstructured":"Dev R, Parsons HA, Palla S, et al. Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer. 2011;117:4551\u20136.","journal-title":"Cancer."},{"key":"717_CR46","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1089\/jpm.2008.0037","volume":"11","author":"HA Parsons","year":"2008","unstructured":"Parsons HA, Delgado-Guay MO, ElOsta B, et al. Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med. 2008;11:964\u20138.","journal-title":"J Palliat Med"},{"issue":"sup11","key":"717_CR47","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1016\/j.pmrj.2015.08.011","volume":"7","author":"LR Webster","year":"2015","unstructured":"Webster LR, Grabois M. Current regulations related to opioid prescribing. PM R. 2015;7(sup11):S236\u201347.","journal-title":"PM R"},{"key":"717_CR48","unstructured":"US Food and Drug Administration. Risk evaluation and mitigation strategy (REMS)forextended-releaseandlong-actingopioidanalgesics. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm163647.htm."},{"key":"717_CR49","first-page":"49661","volume":"79","author":"Drug Enforcement Administration","year":"2014","unstructured":"Drug Enforcement Administration, Department of Justice. Schedules of controlled substances: Rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule. Fed Regist. 2014;79:49661\u201382.","journal-title":"Fed Regist"},{"issue":"5","key":"717_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1155\/2015\/807432","volume":"20","author":"P Pina","year":"2015","unstructured":"Pina P, Sabri E, Lawlor PG. Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic. Pain Res Manag. 2015;20(5):249\u201354.","journal-title":"Pain Res Manag"},{"issue":"4","key":"717_CR51","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2648.2000.t01-1-01560.x","volume":"32","author":"ML Chen","year":"2000","unstructured":"Chen ML, Chang HK, Yeh CH. Anxiety and depression in Taiwanese cancer patients with and without pain. J Adv Nurs. 2000;32(4):944\u201351.","journal-title":"J Adv Nurs"},{"key":"717_CR52","first-page":"173","volume":"17","author":"N Vadivelu","year":"2017","unstructured":"Vadivelu N, Kai AM, Kodumudi G, et al. Pain and psychology-a reciprocal relationship. Ochsner J. 2017;17:173\u201380.","journal-title":"Ochsner J"},{"key":"717_CR53","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1089\/jpm.2006.9.296","volume":"9","author":"E Vignaroli","year":"2006","unstructured":"Vignaroli E, Pace EA, Willey J, et al. The Edmonton symptom assessment system as a screening tool for depression and anxiety. J Palliat Med. 2006;9:296\u2013303.","journal-title":"J Palliat Med"},{"issue":"3","key":"717_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00540-010-0913-6","volume":"24","author":"YC Arai","year":"2010","unstructured":"Arai YC, Matsubara T, Shimo K, Suetomi K, Nishihara M, Ushida T, Kobayashi K, Suzuki C, Kinoshita A, Kondo M, Matsubara S, Hayashi R, Tohyama Y, Nishida K, Arakawa M. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. J Anesth. 2010;24(3):407\u201310.","journal-title":"J Anesth"},{"issue":"11","key":"717_CR55","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.6004\/jnccn.2016.0151","volume":"14","author":"A Syrowatka","year":"2016","unstructured":"Syrowatka A, Chang SL, Tamblyn R, Mayo NE, Meguerditchian AN. Psychotropic and opioid medication use in older patients with breast cancer across the care trajectory: a population-based cohort study. J Natl Compr Cancer Netw. 2016;14(11):1412\u20139.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"717_CR56","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jpainsymman.2011.05.010","volume":"43","author":"C Farriols","year":"2012","unstructured":"Farriols C, Ferr\u00e1ndez O, Planas J, Ortiz P, Mojal S, Ruiz AI. Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period. J Pain Symptom Manag. 2012;43(5):945\u201352.","journal-title":"J Pain Symptom Manag"},{"issue":"11","key":"717_CR57","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1016\/S1470-2045(18)30415-7","volume":"19","author":"S Kaasa","year":"2018","unstructured":"Kaasa S, Loge JH, Aapro M, et al. Integration of oncology and palliative care: a lancet oncology commission. Lancet Oncol. 2018;19(11):e588\u2013653.","journal-title":"Lancet Oncol"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12904-021-00717-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T06:12:49Z","timestamp":1697782369000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-021-00717-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1186\/s12904-021-00717-2","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"13 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research project has been approved by the Institutional Review Board (IRB) of the Ministry of Health, Kuwait (No.272\/2015) within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki. All participants gave written informed consent and their anonymity was preserved.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declared no potential conflicts of interest concerning the research, authorship and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}